RA Capital Management - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 141 filers reported holding OCULAR THERAPEUTIX INC in Q3 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.8%.

Quarter-by-quarter ownership
RA Capital Management ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2021$7,500,000
-29.5%
750,0000.0%0.10%
-39.2%
Q2 2021$10,635,000
-13.6%
750,0000.0%0.17%
-8.1%
Q1 2021$12,308,000
-20.7%
750,0000.0%0.19%
-14.3%
Q4 2020$15,525,000
-25.2%
750,000
-72.5%
0.22%
-42.9%
Q3 2020$20,755,000
-8.6%
2,727,2720.0%0.38%
-14.2%
Q2 2020$22,718,0002,727,2720.44%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q3 2021
NameSharesValueWeighting ↓
SUMMER ROAD LLC 6,122,089$19,223100.00%
Opaleye Management Inc. 6,468,000$20,309,5206.61%
DELTEC ASSET MANAGEMENT LLC 2,061,797$6,474,0431.48%
Endurant Capital Management LP 353,707$1,110,6401.00%
SECTORAL ASSET MANAGEMENT INC 969,350$3,043,7590.59%
NOTTINGHAM ADVISORS, INC. 194,266$609,9950.09%
Covestor Ltd 37,404$1170.09%
GSA CAPITAL PARTNERS LLP 233,582$7330.06%
UBS OCONNOR LLC 342,111$1,074,2290.03%
Polar Asset Management Partners Inc. 263,763$828,2160.02%
View complete list of OCULAR THERAPEUTIX INC shareholders